Rainbow Children's Q1 FY27 Revenue Up 33% YoY

Event Type: Q1 FY27 Earnings Conference Call held post-results announcement.
Date and Time: The call was held on Friday, July 31, 2026, at 10:00 AM IST.
Purpose: Discussion of financial results for the quarter ended June 30, 2026, and strategic business updates.
Management Participants: Dr. Ramesh Kancharla (Chairman and Managing Director), Mr. Abrarali Dalal (Group Chief Executive Officer), Mr. Vikas Maheshwari (Group Chief Financial Officer), and Mr. Saurabh Bhandari (Head Investor Relations & Group Business Analyst).
Availability of Materials: The transcript is available on the company's website at the provided link. No presentation deck or recording availability was mentioned in the disclosure.
UPSI Statement: The document explicitly states that "No unpublished price sensitive information was shared/discussed on the call."

Financial Highlights Discussed:

The quarter ended June 30, 2026 (Q1 FY27) was discussed.
Operating revenue was INR 470 crores, reflecting 33% year-on-year growth.
EBITDA was INR 134.6 crores, a 29.9% year-on-year growth, with a margin of 28.6%.
Profit After Tax (PAT) stood at INR 62.5 crores, a 16% year-on-year growth.
Operational metrics showed growth: Inpatient discharges (+28%), Outpatient consultations (+25%), and Deliveries (+23%).
Occupancy improved to over 41%.
The payor mix remained consistent: Cash (~48%) and Insurance (~42%).
Cash, cash equivalents, and investments stood at INR 613 crores as of June 30, 2026.
Capex for the quarter was approximately INR 56 crores.

Strategic and Forward-Looking Statements:

The company plans to add 2,500 beds in 5 years to reach a total network capacity of 5,000 beds, with an estimated capex of INR 2,200 crores.
Visibility exists for 1,200 beds currently under development.
Specific expansion projects include a 100-bed brownfield hospital in Malad, Mumbai (expected commencement Q1 FY28), acquisition of a 70-bed hospital in Nellore (+30-bed maternal block in 6 months), and a 50-bed leased facility in Guntur (commencing in a couple of months).
Other projects on track: Indore (Q3 FY27), Coimbatore and Gurgaon Sector 56 (Q3 FY28), Gurgaon Sector 44 (Q1 FY29), Pune and Bangalore Seegehalli (FY29).
Management provided a medium-term revenue growth target of ~20% annually, aiming to double revenue in approximately four years.
EBITDA margin guidance is to return to the 24%–25% range (pre-Ind AS basis) by the end of the current financial year (FY27).

The document is an intimation letter enclosing the transcript of the earnings call, submitted pursuant to Regulation 30 of the SEBI LODR Regulations, 2015.
The enclosed transcript was the primary attachment.
No new financial data was disclosed in this specific announcement intimation; all figures were discussed in the enclosed transcript of the call that had already occurred.